Skip to main content
Advertisement

Iroquois Nursing Home: Unnecessary Medication Risks - NY

Healthcare Facility:

Federal inspectors cited Iroquois Nursing Home Inc after finding the facility gave quetiapine, an antipsychotic drug, as a sleep aid without proper documentation or adequate attempts at alternative approaches. The medication was administered even to residents without an insomnia diagnosis.

Iroquois Nursing Home Inc facility inspection

The case centered on Resident #2, who was admitted with an as-needed prescription for the antipsychotic medication. Hospital records indicated the drug was prescribed for agitation, but facility staff expanded its use significantly.

Advertisement

Medical Director #20 explained the facility's approach during a November phone interview with inspectors. "Resident #2 was on the medication for agitation as needed specifically at nighttime when the resident could not sleep," the medical director said. "Even if the resident did not have a diagnosis of insomnia, the medication was used routinely for sleep in the facility."

The medical director described a pattern where elderly residents experience sundowning - increased behavioral problems from late afternoon through nighttime. "In the evening, residents that were Resident #2's age sundown, they are irritable, agitated, and cannot sleep," the director stated.

Staff justified the medication use as comfort care. "If the resident could not sleep at night, the resident could get the quetiapine, and there was nothing wrong with that," the medical director told inspectors. "The idea behind an as needed antipsychotic was for comfort for the patient so they could rest and sleep."

However, the medical director acknowledged that other interventions should be attempted first, including redirection or addressing the resident's specific needs. The challenge, according to staff, was that "Resident #2 was older and could not say what they needed out loud."

The Director of Nursing confirmed during a January interview that the facility had established protocols requiring alternative approaches before antipsychotic administration. "Other interventions should be utilized prior to the resident receiving an as needed antipsychotic," the director stated.

Those interventions included reapproaching, reattempting, and redirecting dementia residents. Staff received training on these techniques, and individual resident behaviors were supposed to be documented in care plans with personalized intervention strategies.

The nursing director explained that Unit Managers, working with Social Work, were responsible for developing behavior care plans. "If a resident had known behaviors, there should be a care plan with personalized interventions," the director said.

According to facility policy, as-needed antipsychotic medications should only be given "if the resident was a danger to themselves or others." When administered, staff were expected to document the specific reason in a corresponding nurse's note.

The medical director acknowledged this documentation requirement. "The reason for the medication was given should be documented by the nurse, as needed medication should not be given without a documented reason," the director told inspectors.

The inspection revealed a disconnect between stated policy and actual practice. While administrators described comprehensive behavioral intervention protocols and documentation requirements, the facility routinely used antipsychotic medication as a sleep aid for residents who couldn't verbally communicate their needs.

The case highlighted broader challenges in nursing home care for residents with dementia and communication difficulties. Staff faced the dilemma of caring for patients who couldn't articulate their needs while following regulations designed to prevent inappropriate medication use.

Federal regulations require nursing homes to ensure residents receive appropriate treatment and that medications are given only when medically necessary. The use of antipsychotic drugs in nursing homes has drawn increased scrutiny from regulators concerned about overmedication of elderly residents.

The facility's approach of using quetiapine "routinely for sleep" regardless of formal insomnia diagnosis raised questions about whether residents received the least restrictive, most appropriate care for their individual needs.

Inspectors found the facility failed to ensure proper medication management protocols were followed, particularly regarding documentation and the use of alternative interventions before administering antipsychotic medications for behavioral management.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Iroquois Nursing Home Inc from 2026-01-30 including all violations, facility responses, and corrective action plans.

Additional Resources

🏥 Editorial Standards & Professional Oversight

Data Source: This report is based on official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).

Editorial Process: Content generated using AI (Claude) to synthesize complex regulatory data, then reviewed and verified for accuracy by our editorial team.

Professional Review: All content undergoes standards and compliance oversight by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal, using professional regulatory data auditing protocols.

Medical Perspective: As emergency medical professionals, we understand how nursing home violations can escalate to health emergencies requiring ambulance transport. This analysis contextualizes regulatory findings within real-world patient safety implications.

Last verified: May 6, 2026 | Learn more about our methodology

📋 Quick Answer

IROQUOIS NURSING HOME INC in JAMESVILLE, NY was cited for violations during a health inspection on January 30, 2026.

The medication was administered even to residents without an insomnia diagnosis.

What this means: Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.

Frequently Asked Questions

What happened at IROQUOIS NURSING HOME INC?
The medication was administered even to residents without an insomnia diagnosis.
How serious are these violations?
Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
What should families do?
Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in JAMESVILLE, NY, (5) Report any new concerns directly to state authorities.
Where can I see the full inspection report?
The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from IROQUOIS NURSING HOME INC or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 335764.
Has this facility had violations before?
To check IROQUOIS NURSING HOME INC's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.